Christopher Bowden
Direktor/Vorstandsmitglied bei Cedilla Therapeutics, Inc.
Aktive Positionen von Christopher Bowden
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 21.04.2021 | - |
Karriereverlauf von Christopher Bowden
Ehemalige bekannte Positionen von Christopher Bowden
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 08.10.2019 | 30.03.2023 |
| Independent Dir/Board Member | 08.10.2019 | 30.03.2023 | |
| AGIOS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 14.05.2014 | 01.09.2021 |
| VIRIDIAN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.08.2017 | 01.10.2020 |
| Independent Dir/Board Member | 10.08.2017 | 01.10.2020 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2006 | 01.05.2014 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01.01.2006 | 01.01.2014 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2003 | 01.01.2006 |
Ausbildung von Christopher Bowden
| Drexel University College of Medicine | Doctorate Degree |
| Lake Forest College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Christopher Bowden
- Erfahrung
